Prediction and prevention of type 1 diabetes.

A. E. Morales, Jin-Xiong She, D. A. Schatz

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

The incidence of type 1 diabetes continues to increase worldwide. Despite major strides in the daily care of patients with the disease, the patients' contribution to overall morbidity and mortality statistics and health care economic burden to society is disproportionately large because of the high rate of microvascular and macrovascular complications. The quest for prevention of type 1 diabetes has been made feasible by the unraveling of the immunogenetics of the disease and the identification of at-risk subjects by an enhanced understanding of the natural history of the prediabetic period. A combination of immunologic, metabolic, and genetic markers can be used to accurately predict the disease in higher-risk relatives and the general population. This has enabled initiation of worldwide trials (Diabetes Prevention Trial-Type 1, European Nicotinamide Diabetes Intervention Trial, and Trial to Prevent Diabetes in Genetically at Risk) aimed at the prevention of the disease. Various promising agents are being considered for use in different at-risk populations in the near future.

Original languageEnglish (US)
Pages (from-to)28-32
Number of pages5
JournalCurrent Diabetes Reports
Volume1
Issue number1
DOIs
StatePublished - Jan 1 2001
Externally publishedYes

Fingerprint

Type 1 Diabetes Mellitus
Immunogenetics
Niacinamide
Natural History
Genetic Markers
Patient Care
Biomarkers
Economics
Morbidity
Delivery of Health Care
Mortality
Incidence
Population

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Prediction and prevention of type 1 diabetes. / Morales, A. E.; She, Jin-Xiong; Schatz, D. A.

In: Current Diabetes Reports, Vol. 1, No. 1, 01.01.2001, p. 28-32.

Research output: Contribution to journalReview article

Morales, A. E. ; She, Jin-Xiong ; Schatz, D. A. / Prediction and prevention of type 1 diabetes. In: Current Diabetes Reports. 2001 ; Vol. 1, No. 1. pp. 28-32.
@article{9555f52116cd4e94968f73dd0e14c3c9,
title = "Prediction and prevention of type 1 diabetes.",
abstract = "The incidence of type 1 diabetes continues to increase worldwide. Despite major strides in the daily care of patients with the disease, the patients' contribution to overall morbidity and mortality statistics and health care economic burden to society is disproportionately large because of the high rate of microvascular and macrovascular complications. The quest for prevention of type 1 diabetes has been made feasible by the unraveling of the immunogenetics of the disease and the identification of at-risk subjects by an enhanced understanding of the natural history of the prediabetic period. A combination of immunologic, metabolic, and genetic markers can be used to accurately predict the disease in higher-risk relatives and the general population. This has enabled initiation of worldwide trials (Diabetes Prevention Trial-Type 1, European Nicotinamide Diabetes Intervention Trial, and Trial to Prevent Diabetes in Genetically at Risk) aimed at the prevention of the disease. Various promising agents are being considered for use in different at-risk populations in the near future.",
author = "Morales, {A. E.} and Jin-Xiong She and Schatz, {D. A.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1007/s11892-001-0007-9",
language = "English (US)",
volume = "1",
pages = "28--32",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Prediction and prevention of type 1 diabetes.

AU - Morales, A. E.

AU - She, Jin-Xiong

AU - Schatz, D. A.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - The incidence of type 1 diabetes continues to increase worldwide. Despite major strides in the daily care of patients with the disease, the patients' contribution to overall morbidity and mortality statistics and health care economic burden to society is disproportionately large because of the high rate of microvascular and macrovascular complications. The quest for prevention of type 1 diabetes has been made feasible by the unraveling of the immunogenetics of the disease and the identification of at-risk subjects by an enhanced understanding of the natural history of the prediabetic period. A combination of immunologic, metabolic, and genetic markers can be used to accurately predict the disease in higher-risk relatives and the general population. This has enabled initiation of worldwide trials (Diabetes Prevention Trial-Type 1, European Nicotinamide Diabetes Intervention Trial, and Trial to Prevent Diabetes in Genetically at Risk) aimed at the prevention of the disease. Various promising agents are being considered for use in different at-risk populations in the near future.

AB - The incidence of type 1 diabetes continues to increase worldwide. Despite major strides in the daily care of patients with the disease, the patients' contribution to overall morbidity and mortality statistics and health care economic burden to society is disproportionately large because of the high rate of microvascular and macrovascular complications. The quest for prevention of type 1 diabetes has been made feasible by the unraveling of the immunogenetics of the disease and the identification of at-risk subjects by an enhanced understanding of the natural history of the prediabetic period. A combination of immunologic, metabolic, and genetic markers can be used to accurately predict the disease in higher-risk relatives and the general population. This has enabled initiation of worldwide trials (Diabetes Prevention Trial-Type 1, European Nicotinamide Diabetes Intervention Trial, and Trial to Prevent Diabetes in Genetically at Risk) aimed at the prevention of the disease. Various promising agents are being considered for use in different at-risk populations in the near future.

UR - http://www.scopus.com/inward/record.url?scp=0141686977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141686977&partnerID=8YFLogxK

U2 - 10.1007/s11892-001-0007-9

DO - 10.1007/s11892-001-0007-9

M3 - Review article

C2 - 12762954

AN - SCOPUS:0141686977

VL - 1

SP - 28

EP - 32

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 1

ER -